Pages that link to "Q42262174"
Jump to navigation
Jump to search
The following pages link to Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial (Q42262174):
Displaying 16 items.
- Parkinsonism in cirrhosis: pathogenesis and current therapeutic options (Q30574245) (← links)
- Clinical significance of basal ganglia alterations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy (Q30771707) (← links)
- Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management (Q34127428) (← links)
- Movement dysfunction and hepatic encephalopathy (Q34450803) (← links)
- Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach (Q35956343) (← links)
- Progress in the treatment of chronic portasystemic encephalopathy (Q40166336) (← links)
- Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy (Q43255873) (← links)
- Levodopa effect on norepinephrine and dopamine brain levels after portocaval shunt in rats (Q48966052) (← links)
- Amino acids in hepatic coma (Q49014870) (← links)
- Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study (Q70152864) (← links)
- Hypothalamic-pituitary dopaminergic function in hepatic failure in man (Q70290417) (← links)
- Effect of L-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis (Q70920220) (← links)
- Management of hepatic encephalopathy (Q71532190) (← links)
- Lack of dissociation of prolactin responses to thyrotropin releasing hormone and metoclopramide in chronic alcoholic men (Q71639582) (← links)
- Controversies in ammonia metabolism: implications for hepatic encephalopathy (Q81166495) (← links)
- Benzodiazepine-like substances and hepatic encephalopathy : implications for treatment (Q85932771) (← links)